ORBIMED ADVISORS LLC Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$9.6B
Holdings
133
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (133 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BSXBOSTON SCIENTIFIC CORP | 23,129,200 | $540.5B | 5640.47% | |
| 2 | AMGNAMGEN INC | 3,033,500 | $461.5B | 4816.29% | |
| 3 | ABBVABBVIE INC | 6,573,100 | $406.9B | 4246.47% | |
| 4 | BMYBRISTOL MYERS SQUIBB CO | 5,055,600 | $371.8B | 3880.18% | |
| 5 | BIIBBIOGEN INC | 1,500,400 | $362.8B | 3786.13% | |
| 6 | ALXNALEXION PHARMACEUTICALS INC | 2,981,411 | $348.1B | 3632.56% | |
| 7 | —ALLERGAN PLC | 1,494,615 | $345.4B | 3604.19% | Call |
| 8 | HCAHCA HOLDINGS INC | 4,098,300 | $315.6B | 3293.42% | |
| 9 | GILDGILEAD SCIENCES INC | 3,072,900 | $256.3B | 2674.94% | |
| 10 | CELGCELGENE CORP | 2,404,677 | $237.2B | 2474.92% | |
| 11 | WCGEURWELLCARE HEALTH PLANS INC | 1,918,500 | $205.8B | 2147.72% | |
| 12 | TMOTHERMO FISHER SCIENTIFIC INC | 1,377,200 | $203.5B | 2123.49% | |
| 13 | ISRGINTUITIVE SURGICAL INC | 297,800 | $197.0B | 2055.38% | |
| 14 | VRTXVERTEX PHARMACEUTICALS INC | 2,189,300 | $188.3B | 1965.18% | |
| 15 | INCYINCYTE CORP | 2,324,678 | $185.9B | 1940.18% | |
| 16 | REGNREGENERON PHARMACEUTICALS | 509,900 | $178.1B | 1858.20% | |
| 17 | UNHUNITEDHEALTH GROUP INC | 1,208,200 | $170.6B | 1780.21% | |
| 18 | —IMPAX LABORATORIES INC | 5,886,700 | $169.7B | 1770.37% | |
| 19 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 1,120,000 | $159.8B | 1667.55% | |
| 20 | AG8AGILENT TECHNOLOGIES INC | 3,565,200 | $158.2B | 1650.33% | |
| 21 | PFEPFIZER INC | 4,243,700 | $149.4B | 1559.22% | |
| 22 | TEVATEVA PHARMACEUTICAL INDS LTD | 2,759,800 | $138.6B | 1446.57% | |
| 23 | —RELYPSA INC | 7,400,000 | $136.9B | 1428.56% | |
| 24 | IRWDIRONWOOD PHARMACEUTICALS INC | 9,949,000 | $130.1B | 1357.43% | |
| 25 | —EXPRESS SCRIPTS HLDG CO | 1,698,600 | $128.8B | 1343.56% | |
| 26 | —MEDIVATION INC | 2,001,400 | $120.7B | 1259.35% | |
| 27 | —WRIGHT MED GROUP N V | 6,945,163 | $120.6B | 1258.86% | Call |
| 28 | ILMNILLUMINA INC | 846,200 | $118.8B | 1239.58% | |
| 29 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,518,500 | $118.1B | 1232.79% | |
| 30 | LLYLILLY ELI & CO | 1,476,800 | $116.3B | 1213.58% | |
| 31 | COOCOOPER COS INC | 676,300 | $116.0B | 1210.82% | |
| 32 | MRKMERCK & CO INC | 1,915,500 | $110.4B | 1151.53% | |
| 33 | —OPHTHOTECH CORP | 2,148,100 | $109.6B | 1143.87% | |
| 34 | MOHMOLINA HEALTHCARE INC | 2,188,000 | $109.2B | 1139.31% | Call |
| 35 | ZBHZIMMER BIOMET HLDGS INC | 862,500 | $103.8B | 1083.46% | |
| 36 | JNJJOHNSON & JOHNSON | 777,600 | $94.3B | 984.27% | |
| 37 | —ACHILLION PHARMACEUTICALS IN | 11,681,600 | $91.1B | 950.80% | |
| 38 | PBYIPUMA BIOTECHNOLOGY INC | 2,964,025 | $88.3B | 921.40% | |
| 39 | —ALLERGAN PLC | 104,200 | $86.9B | 906.38% | |
| 40 | GKOSGLAUKOS CORP | 2,897,938 | $84.5B | 881.81% | |
| 41 | NBIXNEUROCRINE BIOSCIENCES INC | 1,815,474 | $82.5B | 861.03% | |
| 42 | —MALLINCKRODT PUB LTD CO | 1,309,000 | $79.6B | 830.23% | |
| 43 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $76.7B | 800.48% | |
| 44 | —SHIRE PLC | 394,009 | $72.5B | 756.85% | |
| 45 | —MAGELLAN HEALTH INC | 1,090,600 | $71.7B | 748.50% | |
| 46 | HUMHUMANA INC | 339,700 | $61.1B | 637.64% | |
| 47 | INSYEURINSYS THERAPEUTICS INC NEW | 4,688,240 | $60.7B | 633.06% | |
| 48 | MDTMEDTRONIC PLC | 666,299 | $57.8B | 603.31% | |
| 49 | NTLAINTELLIA THERAPEUTICS INC | 2,662,180 | $56.8B | 593.11% | |
| 50 | —BLUEBIRD BIO INC | 1,185,800 | $51.3B | 535.66% | |
| 51 | EWEDWARDS LIFESCIENCES CORP | 511,400 | $51.0B | 532.21% | |
| 52 | —LOXO ONCOLOGY INC | 2,175,857 | $50.4B | 526.30% | |
| 53 | IM8NINSMED INC | 4,358,600 | $43.0B | 448.46% | Call |
| 54 | CICIGNA CORPORATION | 329,600 | $42.2B | 440.21% | |
| 55 | SPYSPDR S&P 500 ETF TR | 200,000 | $41.9B | 437.17% | Put |
| 56 | XBISPDR SERIES TRUST | 745,300 | $40.3B | 420.60% | |
| 57 | EGRXEAGLE PHARMACEUTICALS INC | 1,036,100 | $40.2B | 419.39% | |
| 58 | ARRYEURARRAY BIOPHARMA INC | 10,973,900 | $39.1B | 407.67% | |
| 59 | DVAXDYNAVAX TECHNOLOGIES CORP | 2,403,300 | $35.0B | 365.65% | |
| 60 | ITCIEURINTRA CELLULAR THERAPIES INC | 885,400 | $34.4B | 358.66% | |
| 61 | VRAYQVIEWRAY INC | 7,989,916 | $32.7B | 341.01% | |
| 62 | —DIMENSION THERAPEUTICS INC | 5,397,698 | $32.4B | 337.95% | |
| 63 | OTICEUROTONOMY INC | 1,850,094 | $29.4B | 306.57% | |
| 64 | ASNDASCENDIS PHARMA A S | 2,191,000 | $29.1B | 303.40% | |
| 65 | —LION BIOTECHNOLOGIES INC | 3,382,900 | $27.4B | 285.93% | |
| 66 | EXASEXACT SCIENCES CORP | 2,131,200 | $26.1B | 272.43% | |
| 67 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $25.8B | 269.03% | |
| 68 | SYKSTRYKER CORP | 212,000 | $25.4B | 265.09% | |
| 69 | THCTENET HEALTHCARE CORP | 915,300 | $25.3B | 264.00% | |
| 70 | —SYNERGY PHARMACEUTICALS DEL | 5,976,648 | $22.7B | 236.99% | |
| 71 | —IMMUNOMEDICS INC | 30,000,000 | $20.8B | 217.33% | |
| 72 | GLPGGALAPAGOS NV | 352,700 | $19.6B | 204.15% | |
| 73 | IMGNEURIMMUNOGEN INC | 6,095,647 | $18.8B | 195.92% | |
| 74 | EHTHEHEALTH INC | 1,300,000 | $18.2B | 190.19% | |
| 75 | —NEWLINK GENETICS CORP | 1,581,506 | $17.8B | 185.83% | |
| 76 | —CYNAPSUS THERAPEUTICS INC | 1,140,325 | $17.5B | 182.30% | |
| 77 | XNCRXENCOR INC | 870,822 | $16.5B | 172.57% | |
| 78 | SVASINOVAC BIOTECH LTD | 2,667,500 | $15.8B | 165.06% | |
| 79 | FLBFLUIDIGM CORP DEL | 1,746,100 | $15.8B | 164.53% | |
| 80 | NTRANATERA INC | 1,276,190 | $15.4B | 160.67% | |
| 81 | NUVAGBPNUVASIVE INC | 247,100 | $14.8B | 153.99% | |
| 82 | —FORWARD PHARMA A/S | 798,000 | $14.5B | 151.31% | |
| 83 | —AETNA INC NEW | 116,600 | $14.2B | 148.60% | |
| 84 | IBBISHARES TR | 53,300 | $13.7B | 143.13% | |
| 85 | CAHCARDINAL HEALTH INC | 166,000 | $12.9B | 135.13% | |
| 86 | JAZZJAZZ PHARMACEUTICALS PLC | 90,000 | $12.7B | 132.71% | |
| 87 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $11.7B | 121.97% | |
| 88 | PRQRPROQR THRAPEUTICS N V | 2,305,446 | $11.2B | 116.43% | |
| 89 | —INOTEK PHARMACEUTICALS CORP | 1,391,000 | $10.3B | 107.99% | |
| 90 | —NABRIVA THERAPEUTICS AG | 1,315,000 | $9.9B | 102.92% | |
| 91 | —AFFIMED N V | 3,775,000 | $9.4B | 97.69% | |
| 92 | ABTABBOTT LABS | 237,000 | $9.3B | 97.21% | |
| 93 | CLLSCELLECTIS S A | 350,000 | $9.3B | 97.12% | |
| 94 | SIENUSDSIENTRA INC | 1,357,500 | $8.9B | 93.21% | |
| 95 | —IMMUNOMEDICS INC | 3,802,000 | $8.8B | 92.05% | |
| 96 | —PORTOLA PHARMACEUTICALS INC | 370,900 | $8.8B | 91.34% | |
| 97 | RAREULTRAGENYX PHARMACEUTICAL IN | 169,300 | $8.3B | 86.40% | |
| 98 | MCKMCKESSON CORP | 43,400 | $8.1B | 84.53% | |
| 99 | ASMBASSEMBLY BIOSCIENCES INC | 1,397,100 | $7.8B | 80.91% | |
| 100 | SNDXSYNDAX PHARMACEUTICALS INC | 757,365 | $7.5B | 77.85% |
Page 1 of 2Next